AR225614A1 - Procedimiento para la preparacion de derivados de espiro-(4h-2,3-dihidrobenzopiran o tiopiran(4,5')-oxazolidin)-2',4'-diona utiles en el tratamiento de las complicaciones diabeticas cronicas - Google Patents

Procedimiento para la preparacion de derivados de espiro-(4h-2,3-dihidrobenzopiran o tiopiran(4,5')-oxazolidin)-2',4'-diona utiles en el tratamiento de las complicaciones diabeticas cronicas

Info

Publication number
AR225614A1
AR225614A1 AR277784A AR27778479A AR225614A1 AR 225614 A1 AR225614 A1 AR 225614A1 AR 277784 A AR277784 A AR 277784A AR 27778479 A AR27778479 A AR 27778479A AR 225614 A1 AR225614 A1 AR 225614A1
Authority
AR
Argentina
Prior art keywords
dihidrobenzopiran
thiopiran
diona
oxazolidin
spiral
Prior art date
Application number
AR277784A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR225614A1 publication Critical patent/AR225614A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Moulding By Coating Moulds (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR277784A 1978-08-21 1979-08-21 Procedimiento para la preparacion de derivados de espiro-(4h-2,3-dihidrobenzopiran o tiopiran(4,5')-oxazolidin)-2',4'-diona utiles en el tratamiento de las complicaciones diabeticas cronicas AR225614A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (1)

Publication Number Publication Date
AR225614A1 true AR225614A1 (es) 1982-04-15

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
AR277784A AR225614A1 (es) 1978-08-21 1979-08-21 Procedimiento para la preparacion de derivados de espiro-(4h-2,3-dihidrobenzopiran o tiopiran(4,5')-oxazolidin)-2',4'-diona utiles en el tratamiento de las complicaciones diabeticas cronicas

Country Status (34)

Country Link
US (1) US4200642A (xx)
JP (4) JPS6011914B2 (xx)
AR (1) AR225614A1 (xx)
AT (1) AT366689B (xx)
AU (1) AU535170B2 (xx)
BE (1) BE878311A (xx)
CA (1) CA1121361A (xx)
CH (1) CH639974A5 (xx)
CS (1) CS208129B2 (xx)
DD (1) DD146602A5 (xx)
DE (2) DE2953954C2 (xx)
DK (1) DK258479A (xx)
EG (1) EG14639A (xx)
ES (1) ES483511A1 (xx)
FI (1) FI65255C (xx)
FR (3) FR2442851A1 (xx)
GB (2) GB2028318B (xx)
GR (1) GR71913B (xx)
HU (1) HU179746B (xx)
IE (1) IE48932B1 (xx)
IL (1) IL58076A (xx)
IN (1) IN152416B (xx)
IT (1) IT1123536B (xx)
LU (1) LU81613A1 (xx)
NL (1) NL7906318A (xx)
NO (1) NO792699L (xx)
NZ (1) NZ191350A (xx)
PH (1) PH18091A (xx)
PL (1) PL130686B1 (xx)
PT (1) PT70086A (xx)
SE (1) SE447116B (xx)
SU (1) SU942597A3 (xx)
YU (1) YU41488B (xx)
ZA (1) ZA794379B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
ES515751A0 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CA2376919C (en) 1999-06-18 2008-11-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
JP2003502370A (ja) 1999-06-18 2003-01-21 メルク エンド カムパニー インコーポレーテッド アリールチアゾリジンジオン誘導体およびアリールオキサゾリジンジオン誘導体
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
BR112020008382A2 (pt) 2017-12-21 2020-11-03 Essity Hygiene And Health Aktiebolag artigo absorvente com vedações de canal e método para a fabricação do artigo absorvente
RU2020123382A (ru) 2017-12-21 2022-01-21 Эссити Хайджин Энд Хелт Актиеболаг Впитывающее изделие и способ изготовления впитывающего изделия

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
FR2440949A1 (fr) 1980-06-06
JPS5943954B2 (ja) 1984-10-25
FI792567A (fi) 1980-02-22
GB2033904A (en) 1980-05-29
CS208129B2 (en) 1981-08-31
FR2440950B1 (xx) 1981-06-12
DD146602A5 (de) 1981-02-18
FR2440950A1 (fr) 1980-06-06
IE48932B1 (en) 1985-06-26
DE2933441A1 (de) 1980-02-28
BE878311A (fr) 1980-02-20
PL130686B1 (en) 1984-08-31
HU179746B (en) 1982-12-28
EG14639A (en) 1985-03-31
DE2933441C2 (xx) 1987-04-23
ZA794379B (en) 1980-08-27
FI65255C (fi) 1984-04-10
PL217881A1 (xx) 1981-01-02
AT366689B (de) 1982-04-26
NZ191350A (en) 1984-04-27
IL58076A (en) 1982-07-30
FI65255B (fi) 1983-12-30
YU199979A (en) 1983-06-30
AU5009279A (en) 1980-02-28
GB2028318A (en) 1980-03-05
GR71913B (xx) 1983-08-16
JPS55129288A (en) 1980-10-06
IL58076A0 (en) 1979-12-30
ES483511A1 (es) 1980-09-01
FR2442851A1 (fr) 1980-06-27
AU535170B2 (en) 1984-03-08
JPS6011914B2 (ja) 1985-03-28
GB2028318B (en) 1982-08-04
JPS55129279A (en) 1980-10-06
CH639974A5 (fr) 1983-12-15
CA1121361A (en) 1982-04-06
FR2442851B1 (xx) 1983-06-17
IT1123536B (it) 1986-04-30
JPS55129280A (en) 1980-10-06
IT7925182A0 (it) 1979-08-20
SE7906949L (sv) 1980-02-22
JPS5528996A (en) 1980-02-29
GB2033904B (en) 1982-08-04
PT70086A (en) 1979-09-01
YU41488B (en) 1987-08-31
ATA560579A (de) 1981-09-15
NL7906318A (nl) 1980-02-25
DK258479A (da) 1980-02-22
LU81613A1 (fr) 1980-04-21
PH18091A (en) 1985-03-20
US4200642A (en) 1980-04-29
NO792699L (no) 1980-02-22
FR2440949B1 (xx) 1981-06-12
DE2953954C2 (xx) 1987-12-03
IE791592L (en) 1980-02-21
DE2953954A1 (xx) 1982-09-02
SE447116B (sv) 1986-10-27
JPS5946517B2 (ja) 1984-11-13
IN152416B (xx) 1984-01-07
JPS6011915B2 (ja) 1985-03-28
SU942597A3 (ru) 1982-07-07

Similar Documents

Publication Publication Date Title
AR225614A1 (es) Procedimiento para la preparacion de derivados de espiro-(4h-2,3-dihidrobenzopiran o tiopiran(4,5')-oxazolidin)-2',4'-diona utiles en el tratamiento de las complicaciones diabeticas cronicas
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
AR218795A1 (es) Instrumento porta-clips para el "clipado" de vasos sanguineos
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
MX7194E (es) Procedimiento para aumentar el contenido de solidos de azucar de las frutas
AR223169A1 (es) Derivados de ((pirimidin o 1,3,5-triazin-2-il)-amino-carbonil)-sulfamato de fenilo
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
AR216937A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoretano
BR7904218A (pt) Processo para preparacao de 3-benzil-3-azabiciclo-(3,1,0)-hexano
MX151516A (es) Proceso mejorado para la preparacion de mercaptanos
AR225276A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoroetano
MX158871A (es) Procedimiento para la preparacion de 1,2-dicloroetano
ES241316Y (es) Dispositivo ensanchador para el tratamiento de displasais dela cadera.
ES487923A0 (es) Un procedimiento para la preparacion de espiro-quinolilludantoinas, utiles como inhibidores de la aldosa-reductasa para el tratamiento de las complicaciones cronicas de la diabetes
IT7825497A0 (it) Derivati di 1,2,4-ossadiazolo, loro preparazione e loro applicazione in terapia.
MX153700A (es) Mejoras en procedimiento para la preparacion de 1,2-dicloroetano
IT7805198A0 (it) Procedimento per la fabbricazione di coltelli.
AR225134A1 (es) Procedimiento para la preparacion de acidos 3,7-disustituidos-3-cefem-4-carboxilicos
AR220368A1 (es) Procedimiento para la produccion de alcanos sustituidos por atomos de cloro y/o grupos sulfocloruro
MX4770E (es) Procedimiento mejorado para la preparacion de trans-3,3,5-trimetilciclohexil etileter
IT7950044A0 (it) Procedimento per la preparazione di 1,2-polibutadiene
MX5508E (es) Procedimiento para la preparacion de o-carbamoiloximas de 2,3-dihidro-4h-1-benzopiran-4-ona
ES491356A0 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
ES2021318B3 (es) Procedimiento para la fabricacion de direcciones por cremallera con transmisiones variables
ES246356Y (es) Maquina para la fabricacion de pernios,goznez y similares